NovinoPath
Healthcare Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21410 24th Ave, Bayside, New York, 11360...Website
www.novinopath.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About NovinoPath
NovinoPath Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NovinoPath your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once NovinoPath has new funding data
Earning: See what the market has to say on NovinoPath recently announced quarterly report
Check out if NovinoPath is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at NovinoPath
Check if NovinoPath has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if NovinoPath had a recent Job posting/layoffs
Product Launch: Get notified when NovinoPath launches new products
NovinoPath, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at NovinoPath
Find 2 more new buyers
NovinoPath Tech Stack
A closer look at the technologies used by NovinoPath
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NovinoPath
NovinoPath is a CLIA-certified pathology laboratory located in Queens, NY, and Fort Lauderdale, FL, specializing in anatomic and cytopathology services. The company is known for its digitally-driven pathology solutions, including AI-assisted workflows and fast turnaround times. NovinoPath offers flexible service models and participates with most in... Read More
